GABAergic cortical neuron chromatin as a putative target to treat schizophrenia vulnerability.
D000818:Animals; D015816:Cell Adhesion Molecules, Neuronal / Q000378:metabolism; D042002:Chromatin Assembly and Disassembly / Q000187:drug effects / Q000235:genetics*; D000076123:DNA (Cytosine-5-)-Methyltransferase 1; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000187:drug effects / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D016326:Extracellular Matrix Proteins / Q000378:metabolism; D005968:Glutamate Decarboxylase / Q000378:metabolism; D056572:Histone Deacetylase Inhibitors; D006655:Histone Deacetylases / Q000378:metabolism; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism; D009419:Nerve Tissue Proteins; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D017397:Prefrontal Cortex / Q000187:drug effects / Q000378:metabolism* / Q000503:physiopathology; D000091042:Reelin Protein; D012559:Schizophrenia / Q000188:drug therapy / Q000235:genetics* / Q000378:metabolism; D012697:Serine Endopeptidases; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D015816:Cell Adhesion Molecules, Neuronal; D004791:Enzyme Inhibitors; D016326:Extracellular Matrix Proteins; D056572:Histone Deacetylase Inhibitors; D007527:Isoenzymes; D009419:Nerve Tissue Proteins; D000091042:Reelin Protein; D005680:gamma-Aminobutyric Acid; D000076123:DNA (Cytosine-5-)-Methyltransferase 1; D004248:DNA (Cytosine-5-)-Methyltransferases; C000717127:RELN protein, human; D012697:Serine Endopeptidases; D006655:Histone Deacetylases; D005968:Glutamate Decarboxylase; C402565:glutamate decarboxylase 1